
2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …
Speaking at its 2016 Capital Market Day about the progress it had made towards its 2018 objectives, CEO Stefan Oschmann …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

